CONMED (CNMD) News Today

$74.72
-0.78 (-1.03%)
(As of 05/17/2024 ET)
CONMED Co. (NYSE:CNMD) Receives Consensus Recommendation of "Moderate Buy" from Analysts
CONMED Co. (NYSE:CNMD - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The ave
CONMED Co. (NYSE:CNMD) Shares Sold by Principal Financial Group Inc.
Principal Financial Group Inc. trimmed its stake in CONMED Co. (NYSE:CNMD - Free Report) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 600,334 shares of the company's stock after selling 13,021 shares dur
CONMED Co. (NYSE:CNMD) Director Buys $99,872.92 in Stock
Barbara J. Schwarzentraub Purchases 1,442 Shares of CONMED Co. (NYSE:CNMD) Stock
CONMED Co. (NYSE:CNMD - Get Free Report) Director Barbara J. Schwarzentraub purchased 1,442 shares of CONMED stock in a transaction that occurred on Wednesday, May 8th. The stock was acquired at an average price of $69.26 per share, with a total value of $99,872.92. Following the transaction, the director now owns 1,442 shares in the company, valued at $99,872.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
CONMED Co. (NYSE:CNMD) Director Martha Goldberg Aronson Buys 2,000 Shares
CONMED Co. (NYSE:CNMD - Get Free Report) Director Martha Goldberg Aronson bought 2,000 shares of the firm's stock in a transaction dated Monday, May 6th. The shares were acquired at an average price of $70.98 per share, for a total transaction of $141,960.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $141,960. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Lisanti Capital Growth LLC Takes Position in CONMED Co. (NYSE:CNMD)
Lisanti Capital Growth LLC purchased a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 40,570 shares of the company's stock, valued at approximately $4,443,0
CONMED's (CNMD) Buy Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $107.00 price target on shares of CONMED in a research note on Monday.
Fisher Asset Management LLC Sells 25,487 Shares of CONMED Co. (NYSE:CNMD)
Fisher Asset Management LLC lowered its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 277,809 shares of the company's stock
Insider Buying: CONMED Co. (NYSE:CNMD) COO Acquires 3,000 Shares of Stock
CONMED Co. (NYSE:CNMD - Get Free Report) COO Pat Beyer bought 3,000 shares of CONMED stock in a transaction on Tuesday, April 30th. The stock was acquired at an average cost of $68.30 per share, for a total transaction of $204,900.00. Following the acquisition, the chief operating officer now owns 10,807 shares in the company, valued at approximately $738,118.10. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Mountain Pacific Investment Advisers Inc. ID Purchases 48,050 Shares of CONMED Co. (NYSE:CNMD)
Mountain Pacific Investment Advisers Inc. ID raised its position in CONMED Co. (NYSE:CNMD - Free Report) by 33.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,426 shares of the company's stock after purchasing a
CONMED First Quarter 2024 Earnings: Beats Expectations
CONMED (NYSE:CNMD) Given New $75.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. dropped their price objective on shares of CONMED from $115.00 to $75.00 and set an "overweight" rating for the company in a report on Thursday.
Analyst Scoreboard: 5 Ratings For Conmed
Jennison Associates LLC Has $37.79 Million Stock Holdings in CONMED Co. (NYSE:CNMD)
Jennison Associates LLC trimmed its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 5.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 345,115 shares of the company's stock after sellin
Conmed: Q1 Earnings Snapshot
Conmed Corp. Q1 Income Climbs, but misses estimates
CONMED (NYSE:CNMD) Issues FY 2024 Earnings Guidance
CONMED (NYSE:CNMD) updated its FY 2024 earnings guidance. The company provided EPS guidance of 4.250-4.350 for the period, compared to the consensus estimate of 4.330. The company also issued revenue guidance of $1.3 billionillion-$1.4 billionillion, compared to the consensus estimate of $1.4 billionillion.
CONMED (NYSE:CNMD) Reaches New 12-Month Low at $70.34
CONMED (NYSE:CNMD) Sets New 1-Year Low at $70.34
abrdn plc Sells 22,338 Shares of CONMED Co. (NYSE:CNMD)
abrdn plc lessened its position in CONMED Co. (NYSE:CNMD - Free Report) by 9.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 212,854 shares of the company's stock after selling 22,338 shares during the period. ab
Conmed is about to announce its earnings — here's what to expect
Knights of Columbus Asset Advisors LLC Has $5.02 Million Stock Holdings in CONMED Co. (NYSE:CNMD)
Knights of Columbus Asset Advisors LLC grew its position in CONMED Co. (NYSE:CNMD - Free Report) by 144.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,850 shares of the company's stock after purch
CONMED (NYSE:CNMD) Reaches New 1-Year Low at $71.25
CONMED (NYSE:CNMD) Hits New 52-Week Low at $71.25
CONMED (NYSE:CNMD) Stock Price Down 5.4%
CONMED (NYSE:CNMD) Shares Down 5.4%
CONMED (NYSE:CNMD) Sets New 12-Month Low at $74.19
CONMED (NYSE:CNMD) Sets New 12-Month Low at $74.19
Should You Invest in CONMED (CNMD)?
Peregrine Capital Management LLC Sells 16,079 Shares of CONMED Co. (NYSE:CNMD)
Peregrine Capital Management LLC trimmed its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 14.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,408 shares of t
3 Retirement Stocks to Buy at a 52-Week Low in March
CONMED (NYSE:CNMD) Hits New 52-Week Low at $74.80
CONMED (NYSE:CNMD) Sets New 52-Week Low at $74.80
CNMD Apr 2024 120.000 call
Get CONMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.

The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.

CNMD Media Mentions By Week

CNMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CNMD
News Sentiment

0.96

0.51

Average
Medical
News Sentiment

CNMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CNMD Articles
This Week

6

3

CNMD Articles
Average Week

Get CONMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:CNMD) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners